List of Celera Corporation patents

Patents where

Current Assignee

Name

Celera Corporation

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7608413 Kidney disease targets and uses thereof	Patent 7608413 was granted and assigned to Celera Corporation on October, 2009 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7608413	October 27, 2009
‌ US Patent 11401555 Genetic polymorphisms associated with stroke, methods of detection and uses thereof	Patent 11401555 was granted and assigned to Celera Corporation on August, 2022 by the United States Patent and Trademark Office.	Celera Corporation	Celera Corporation	United States Patent and Trademark Office	11401555	August 2, 2022
‌ US Patent 8975022 Genetic polymorphisms associated with psoriasis, methdos of detection and uses thereof	Patent 8975022 was granted and assigned to Celera Corporation on March, 2015 by the United States Patent and Trademark Office.	Celera Corporation	Celera Corporation	United States Patent and Trademark Office	8975022	March 10, 2015
‌ US Patent 7993833 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof	Patent 7993833 was granted and assigned to Celera Corporation on August, 2011 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7993833	August 9, 2011
‌ US Patent 7587283 Growth and baseline identification determination for amplification data	Patent 7587283 was granted and assigned to Celera Corporation on September, 2009 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7587283	September 8, 2009
‌ US Patent 7842467 Breast disease targets and uses thereof	Patent 7842467 was granted and assigned to Celera Corporation on November, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7842467	November 30, 2010
‌ US Patent 7998689 Detection of CXADR protein for diagnosis of kidney cancer	Patent 7998689 was granted and assigned to Celera Corporation on August, 2011 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7998689	August 16, 2011
‌ US Patent 7863021 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof	Patent 7863021 was granted and assigned to Celera Corporation on January, 2011 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7863021	January 4, 2011
‌ US Patent 8216786 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof	Patent 8216786 was granted and assigned to Celera Corporation on July, 2012 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	8216786	July 10, 2012
‌ US Patent 7833706 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof	Patent 7833706 was granted and assigned to Celera Corporation on November, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7833706	November 16, 2010
‌ US Patent 11408034 Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof	Patent 11408034 was granted and assigned to Celera Corporation on August, 2022 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	11408034	August 9, 2022
‌ US Patent 7521195 Lung disease targets and uses thereof	Patent 7521195 was granted and assigned to Celera Corporation on April, 2009 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7521195	April 21, 2009
‌ US Patent 7482117 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof	Patent 7482117 was granted and assigned to Celera Corporation on January, 2009 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7482117	January 27, 2009
‌ US Patent 7452974 Isolated human squalene synthase and composition thereof	Patent 7452974 was granted and assigned to Celera Corporation on November, 2008 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7452974	November 18, 2008
‌ US Patent 10982281 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof	Patent 10982281 was granted and assigned to Celera Corporation on April, 2021 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	10982281	April 20, 2021
‌ US Patent 7776555 Colon disease targets and uses thereof	Patent 7776555 was granted and assigned to Celera Corporation on August, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7776555	August 17, 2010
‌ US Patent 7695916 Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof	Patent 7695916 was granted and assigned to Celera Corporation on April, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7695916	April 13, 2010
‌ US Patent 7807392 Lung disease targets and uses thereof	Patent 7807392 was granted and assigned to Celera Corporation on October, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7807392	October 5, 2010
‌ US Patent 7892760 Lung cancer markers, and uses thereof	Patent 7892760 was granted and assigned to Celera Corporation on February, 2011 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7892760	February 22, 2011
‌ US Patent 7947451 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof	Patent 7947451 was granted and assigned to Celera Corporation on May, 2011 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7947451	May 24, 2011
‌ US Patent 8227189 Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof	Patent 8227189 was granted and assigned to Celera Corporation on July, 2012 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	8227189	July 24, 2012
‌ US Patent 8486392 Methods and compositions for diagnosing and treating diseases	Patent 8486392 was granted and assigned to Celera Corporation on July, 2013 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	8486392	July 16, 2013
‌ US Patent 7727725 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof	Patent 7727725 was granted and assigned to Celera Corporation on June, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7727725	June 1, 2010
‌ US Patent 7781168 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof	Patent 7781168 was granted and assigned to Celera Corporation on August, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7781168	August 24, 2010
‌ US Patent 7842466 Colon disease targets and uses thereof	Patent 7842466 was granted and assigned to Celera Corporation on November, 2010 by the United States Patent and Trademark Office.		Celera Corporation	United States Patent and Trademark Office	7842466	November 30, 2010

Results per page:

62 results

0 selected

62 results

0 selected